佩马纤维酸对脑血管动脉样硬化在中风和高甘油三血症患者中的影响
Takao Hoshino1, Kentaro Ishizuka1, Misa Seki1
1Department of Neurology, Tokyo Women's Medical University Hospital.
Journal of atherosclerosis and thrombosis
|December 1, 2024
概括
米纤维酸有效降低甘油三,并减少中风患者的炎症与高甘油三血症. 该药物还显示出减缓动脉硬化在内和外动脉中进展的潜力.
科学领域:
- 心血管医学 心血管医学
- 药理学 药理学是指药理学的学科.
- 神经学 神经学
背景情况:
- 过高甘油三血是动脉样硬化疾病的重要危险因素,包括中风.
- 脑血管动脉样硬化的进展仍然是有史以来中风和高甘油水平的患者的担忧.
- 选择性氧酶增殖器激活受体α (PPARα) 调节器为控制失脂症和心血管风险提供了潜在的治疗策略.
研究的目的:
- 评估pemafibrate在减轻脑血管动脉样硬化进展方面的疗效.
- 评估pemafibrate对中风和高甘油三血症患者的脂质样本和炎症标志物的影响.
- 为了研究pemafibrate对动脉内膜介质厚度和内动脉狭窄的作用.
主要方法:
- 一项前性单臂研究,涉及99名患有高甘油三血症的患者,并有非心血管血栓性中风或TIA的病史.
- 患者在两年内接受了佩马菲布拉特 (0.2毫克或0.1毫克/天).
- 主要结局:动脉内心介质厚度 (IMT) 的变化;次要结局:生物标志物的变化和内动脉狭窄.
主要成果:
- 纤维酸显著降低了甘油三水平 (269至139毫克/分升),并增加了HDL-C (49至54毫克/分升).
- 观察到高灵敏性C-反应蛋白和白蛋白-6水平的显著降低.
- 内动脉中平均IMT在左侧显著减少 (P=0.009) 和右侧边缘显著 (P=0.053).
- 内动脉狭窄症在18.8%的病例中呈现回归,在8.3%的病例中呈现进展.
结论:
- 纤维酸证明TG降低和抗炎作用.
- 该药物可以减轻动脉样硬化在内和外动脉的进展.
- 佩马菲布拉特为中风患者具有高甘油血症提供了一个有前途的治疗选择.
相关概念视频
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
532
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
532
01:25Blood Studies for Cardiovascular System III: Serum Lipid Profile
132
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
132
01:29Cholesterol: Significance and Regulation
504
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
504
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
468
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
468
01:26Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
141
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
141
01:22Alzheimer's Disease: Treatment
163
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
163